Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SE-7552
Cat. No.:
OB0425LY-221
Appearance:
Solid
Purity:
98.35%
Identity:
Confirmed by NMR and MS.
Size:
Add to basket
Product Overview
Description:
SE-7552 is a small molecule compound used to target specific signaling pathways or enzymatic activities.
Synonyms:
SE7552; 2243575-79-1; 5-(5-(Difluoromethyl)-1,3,4-oxadiazol-2-yl)-N-(1-(4-fluorophenyl)ethyl)pyrimidin-2-amine
CAS No.:
2243575-79-1
Compound CID:
135320929
Formula:
C15H12F3N5O
Formula Weight:
335.28
Specification
Target:
HDAC
Pathway:
Cell cycle/DNA damage; Epigenetics
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
SE-7552 can be used to exert anti-obesity effects in diet-induced obese mice.
